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INTRODUCTION
Since 1949, when Hench and Kendall introduced the use of cortisone and hydro-
cortisone, a voluminous literature has accumulated concerning the employment of
these agents in allergic diseases. Steroid therapy requires careful thought in view
of the evidence that long term treatment can react adversely on the pituitary-
adrenal axis. Nevertheless, an injectable steroid may be used in the treatment of
chronic hay fever, and I have undertaken a trial in my own practice. In this small
series of cases a study of the clinical effects, and a laboratory investigation of
adrenal function are compared.
Hay fever is a hypersensitive state characterised by hyperactivity of the body
to contact with a foreign substance in an amount which would not disturb a non-
allergic individual. Allergy is a chronic and progressive disease, but hypo.
sensitisation in some way alters the basic hypersensitivity and thereby helps to
prevent the allergic symptoms from being multiple. Total avoidance of exposure
to the incriminating allergen is usually impossible as it is airborne and inhaled, so
hyposensitisation is the more practicable treatment. However, not every chronic
case responds to this desensitisation programme, and in addition, it is time
consuming for the patient and doctor alike, and new methods have to be explored
which may be more efficacious.
Hay fever has been treated with a variety of adrenocorticosteroids. Much
research has been performed to develop new adrenocorticosteroids which would
possess greater biological activity and maintain an adequate ratio of glucocorticoid
to mineralocorticoid activity. Alterations in the chemical configurations of the
steroid nucleus and its chains produced triamcinolone. 16 - a - hydroxlyation
markedly decreased mineralocorticoid activity and abolished the sodium retaining
properties of 9 - a - fluorosteroids without destroying their glucocorticoid activity.
It is one and a half to two times more potent than prednisolone. The greater
therapeutic activity of triamcinolone is not accompanied by a corresponding
increase in production of adverse effects. Triamcinolone Acetonide (the corti-
costeroid used in this trial) suppresses the clinical manifestation of hay fever and
affords symptomatic relief. The mechanism of action is not entirely clear. In
allergic conditions the union of antigen and antibody acts as a stress and either
alone, or with the stress stimuli, e.g., psychogenic influences or infection, causes
a liberation of histamine, acetyl choline, serotonin, and unknown substances which
trigger allergic tissue responses. The exact mode of action is not clearly under-
stood. It is suggested that they act locally upon the sensitised tissue cells, decrease
the reactivity of the shock organs to specific antigens and stress and suppress local
tissue responses rendering the cells less subject to injury. They increase permeability
176and prevent formation of oedema and granulation tissue. Triamcinolone decreases
oedema and increases the permeability of basement membrane. This is interpreted
as being caused by the arrest of muco-protein breakdown and restoration of the
normal state.
DESIGN
The aim of this study was to test the efficacy and note any adverse reactions
of triamcinolone acetonide following one 80 mg I-M injection in the gluteus
maximus in patients with hay fever.
Patients included in the trial were between the ages of 25 and 45 and were of
both sexes. They had symptoms of seasonal hay fever this year and also a history of
severe seasonal hay fever over a minimum of three years which had responded
poorly to other medicaments, e.g., antihistamines. Patients with a history of
tuberculosis, hypertension, diabetes and duodenal ulcer were excluded. All patients
were otherwise in good health and apyrexic.
The use of any exogenous steroid will affect the pituitary-adrenal axis. It was
therefore decided to estimate cortisol levels at specific times following the injection.
Each patient had cortisol estimated by withdrawal of blood from a vein in
the antecubital fossa before the injection of 80 mg. triamcinolone acetonide was
given intramuscularly in the gluteus maximus. Cortisol estimations were carried
out at 24 hours, 48 hours, 7 days, 14 days, and 21 days after the injection.
Response to injection was noted at each interview and patients were given a diary
card to record symptoms of hay fever and/or side effects. Only patients who were
willing and able to attend for repeated investigations at a fixed time - viz. 10 a.m.,
were studied. The time factor was considered very important as it is well known
that cortisol levels vary along a 24 hours phasing scale under conditions s-tandard-
ised to eliminate stimulation other than daily routine.
The range of normal values of any body constituent, a time honoured standard,
does not take into account the specific time at which the level was determined
but rather allows for the existing variability of body function throughout the
24 hours. Circadian rhythms contribute largely to normal variations and this
physiological regulation must be understood if disturbances of health are to be
recognised and interpreted, and thus prevented or corrected. Depending on their
time dimension, circadian rhythms either hinder or further studies in adaptive
responses, and must to some extent dictate the experimental approach. Possibly
the simplest approach is to attempt to eliminate their effect by fixed sampling times
as is done in this series. The adrenal cycle is modulated by superimposed or
juxtaposed endocrines and the interactions involved await further study. This
field of study has a long history and has been reviewed repeatedly (Conroy and
Mills, 1970).,
The method of cortisol estimation used was that described by Mattingly (1962).
The preparation under study was an aqueous suspension of triamcinolone
acetonide, each ml. containing 40 mg of the corticosteroid with sodium chloride
for isotonicity, 0.9 per cent benzyl alcohol as a preservative, and 0.75 per cent
sodium caboxymethyl cellulose, and 0.04 per cent polysorbate 80 as excipients.
2 ml. of this preparation was administered intramuscularly to each patient of the
series, injections being given into the gluteal muscle in every case.
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Clinical results were regarded as excellent in 12 of the 18 cases whose symptoms
subsided rapidly, usually within 12 to 48 hours after injection, and did not reappear
thereafter, so that no further supportive therapy was required. The clinical results
were considered as good in five additional patients. In these patients there was
marked symptomatic relief following the injection of triamcincolone acetonide
although very mild symptoms recurred which required no further supportive treat-
ment. One patient had a recurrence of his hay fever four weeks after the initial
injection which necessitated further therapy. Response of three patients who in
previous years had received desensitisation injections was dramatic and much
appreciated, in that only one injection was required. The remaining 15 patients,
who in previous years had antihistamines, were relieved since they were no longer
drowsy at work. Side effects were negligible in the series. Three patients remarked
on flushing of the face within 36 hours of injection.
The clinical benefits from this series compare favourably with the smaller series
treated with two 80 mg. doses of methyl prednisolone acetate given at an interval
of two weeks (Ganderton and James, 1970).
The cortisol estimations show depression of the pituitary adrenal axis within
24 hours. This lasted for varying times, but within three weeks the cortisol level
returned to its initial level. Individual variations can be seen and response to
emotional factors may explain the elevated levels in one case at two weeks in
comparison with three weeks after the injection. The table shows the actual cortisol
TABLE
Cortisol Level mgs. per cent
Before 24 hrs. 48 hrs. 1/52 2/52 3/52
Sex Age injection after after after after after
M 39 10 4 3 3.5 4 9
M 28 21 9.5 4 2.5 3.5 17
M 31 10.5 8 5 2 3 10
M 28 21 9 5 2 21 31
M .34 13 9 5 5.5 9 27
M 40 9.5 2 2 7 9.5 10
M 32 15 6.5 5 9.5 9.3 17
M 32 17.5 5.5 4 9.5 9 14.5
M 45 11.5 4.5 2 3.5 9.5 13.5
F 26 7 3.5 2 5.5 8 9.5
F 28 19 14 9.5 8.5 12 13.5
M 35 7 5 2 7.5 12 16
M 35 13 9 5 7 9 11
F 26 9 2 2 5 9 10
M 27 15 8.5 3 7.5 11 13.5
M 25 11 4 2 4.5 9 10
F 26 14.5 7 4 9.5 9 13.5
F 28 17.5 6 2 7 9.5 16
178levels obtained. This part of the study was thought to be of particular importance
as any long-term influence on the pituitary-adrenal axis would be a definite
drawback to the widespread use of triamcinolone acetonide injections for hay
fever. It would appear from this study that recovery from adrenal suppression
occurred in every case.
The small incidence of side effects may be attributed to the strict criteria used
for selecting the personnel in the trial, and I feel that in the future, more use may
be made of triamcinolone acetonide in this type of susceptible hay fever victim.
SUMMARY
The use of a synthetic corticosteroid in the treatment of hay fever is described
and the effects of the treatment on adrenal function are considered. It is sugested
that treatment with triamcinolone can be of value to the susceptible hay fever
sufferer.
The author is indebted to Mr. D. W. Neill, Chief Biochemist, Royal Victoria Hospital, in
whose department the cortisol estimations were carried out, and who assisted in the production
of this paper.
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